New generation of prognostic factors in muscle invasive bladder cancer.
Abi-Aad
A S
AS
D002295:Carcinoma, Transitional Cell / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D066246:ErbB Receptors; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009389:Neovascularization, Pathologic; D011379:Prognosis; D016271:Proto-Oncogene Proteins c-myc; D016159:Tumor Suppressor Protein p53 / Q000235:genetics; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy*
D016271:Proto-Oncogene Proteins c-myc; D016159:Tumor Suppressor Protein p53; D066246:ErbB Receptors